Risk Factors for Small Bowel Crohn’s Disease Recurrence after Total Proctocolectomy

BACKGROUND: Surgical management of Crohn's disease of the colon and rectum frequently requires total proctocolectomy with end ileostomy. There is limited data on the need for Crohn's disease-directed therapy and the prevalence of recurrence after surgery. OBJECTIVE: To determine the risk of small bowel Crohn's disease recurrence and evaluate risk factors for postoperative recurrence after total proctocolectomy with end ileostomy. DESIGN: Retrospective cohort study. SETTINGS: Multistate tertiary healthcare system. PATIENTS: Adult patients with Crohn's disease undergoing total proctocolectomy with end ileostomy between 2014-2023. MAIN OUTCOME MEASURES: The primary outcome was small bowel Crohn's disease recurrence. RESULTS: A total of 193 patients with a median age of 45 years (IQR, 34-61) were included. Over half of the patients (n = 102, 52.9%) had a history of small bowel Crohn's disease and the majority (n = 134, 69.4%) received biologic therapy prior to surgery. The median follow-up time was 4.8 years (IQR, 2.0-7.6). Postoperatively, 30.6% of patients (n = 59) received biologic therapy. Thirty-five patients (18.1%) had small bowel Crohn's disease recurrence for an estimated 5-year recurrence-free rate of 80.2% (95% CI, 73.0-85.7). Seven patients (3.6%) developed small bowel Crohn's disease recurrence requiring surgery for an estimated 5-year surgical recurrence-free rate of 94.7% (95% CI, 89.0-97.5). On multivariable analysis, history of small bowel Crohn's disease (HR 2.17; 95% CI' 1.04-4.54) and diagnosis at age <18 years (HR 2.31; 95% CI'1.1-4.86) were associated with small bowel Crohn's disease recurrence. LIMITATIONS: Retrospective design and non-standardized follow-up. CONCLUSIONS: Patients undergoing total proctocolectomy with end ileostomy for Crohn's disease have approximately a 20% risk of small bowel recurrence at 5 years but a low risk of requiring surgical intervention. Patients with a history of small bowel Crohn's disease and younger age at diagnosis have a higher risk of recurrence and may warrant consideration of more frequent surveillance and medical prophylaxis. See Video Abstract.

Authors

Institutions

Publication Details

Journal
Diseases of the Colon & Rectum
Published
2026-06-12
DOI
https://doi.org/10.1097/dcr.0000000000004329
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk Factors for Small Bowel Crohn’s Disease Recurrence after Total Proctocolectomy

William Perry, Ana Sofía Ore, Nicholas P. McKenna, Maxwell D. Mirande et al.
Diseases of the Colon & Rectum
Inflammatory Bowel Disease
article

Risk Factors for Small Bowel Crohn’s Disease Recurrence after Total Proctocolectomy

William Perry, Ana Sofía Ore, Nicholas P. McKenna, Maxwell D. Mirande, E V Flaherty, Danilo Tueme de la Peña, Ian Reynolds, Kellie L. Mathis, Matas Jakubaukas, Ahmed A. Alaoui, Luca Stochhi, Nitin Mishra
article en

Abstract

BACKGROUND: Surgical management of Crohn's disease of the colon and rectum frequently requires total proctocolectomy with end ileostomy. There is limited data on the need for Crohn's disease-directed therapy and the prevalence of recurrence after surgery. OBJECTIVE: To determine the risk of small bowel Crohn's disease recurrence and evaluate risk factors for postoperative recurrence after total proctocolectomy with end ileostomy. DESIGN: Retrospective cohort study. SETTINGS: Multistate tertiary healthcare system. PATIENTS: Adult patients with Crohn's disease undergoing total proctocolectomy with end ileostomy between 2014-2023. MAIN OUTCOME MEASURES: The primary outcome was small bowel Crohn's disease recurrence. RESULTS: A total of 193 patients with a median age of 45 years (IQR, 34-61) were included. Over half of the patients (n = 102, 52.9%) had a history of small bowel Crohn's disease and the majority (n = 134, 69.4%) received biologic therapy prior to surgery. The median follow-up time was 4.8 years (IQR, 2.0-7.6). Postoperatively, 30.6% of patients (n = 59) received biologic therapy. Thirty-five patients (18.1%) had small bowel Crohn's disease recurrence for an estimated 5-year recurrence-free rate of 80.2% (95% CI, 73.0-85.7). Seven patients (3.6%) developed small bowel Crohn's disease recurrence requiring surgery for an estimated 5-year surgical recurrence-free rate of 94.7% (95% CI, 89.0-97.5). On multivariable analysis, history of small bowel Crohn's disease (HR 2.17; 95% CI' 1.04-4.54) and diagnosis at age <18 years (HR 2.31; 95% CI'1.1-4.86) were associated with small bowel Crohn's disease recurrence. LIMITATIONS: Retrospective design and non-standardized follow-up. CONCLUSIONS: Patients undergoing total proctocolectomy with end ileostomy for Crohn's disease have approximately a 20% risk of small bowel recurrence at 5 years but a low risk of requiring surgical intervention. Patients with a history of small bowel Crohn's disease and younger age at diagnosis have a higher risk of recurrence and may warrant consideration of more frequent surveillance and medical prophylaxis. See Video Abstract.

Diseases of the Colon & Rectum
Mayo Clinic (US), Jacksonville College (US), Beaumont Hospital (IE), Mayo Clinic in Arizona (US), Mayo Clinic Hospital (US), Colon and Rectal Surgery Associates (US)
Good health and well-being
Openalex Percentile: Top 6%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.